1377 related articles for article (PubMed ID: 28685847)
1. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
[TBL] [Abstract][Full Text] [Related]
2. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
3. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation.
Liu HR; Zhao J
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897
[TBL] [Abstract][Full Text] [Related]
4. Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway.
Wang JJ; Li ZF; Li XJ; Han Z; Zhang L; Liu ZJ
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28724603
[TBL] [Abstract][Full Text] [Related]
5. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway.
Mao XW; Xiao JQ; Li ZY; Zheng YC; Zhang N
Exp Mol Med; 2018 Jan; 50(1):e429. PubMed ID: 29350680
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway.
Peng L; Liu Z; Xiao J; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2017 Jul; 38(1):301-308. PubMed ID: 28586066
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
9. Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1.
Lin X; Zheng L; Song H; Xiao J; Pan B; Chen H; Jin X; Yu H
Exp Mol Pathol; 2017 Jun; 102(3):522-532. PubMed ID: 28506766
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
11. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
Wang Y; Yue D
Cancer Med; 2019 May; 8(5):2278-2287. PubMed ID: 30883036
[TBL] [Abstract][Full Text] [Related]
12. CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/β-catenin signaling pathway.
Mao XW; Xiao JQ; Xu G; Li ZY; Wu HF; Li Y; Zheng YC; Zhang N
Oncotarget; 2017 Sep; 8(44):77241-77253. PubMed ID: 29100384
[TBL] [Abstract][Full Text] [Related]
13. Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 through the Wnt Signaling Pathway.
Song XF; Wang QH; Huo R
Pathol Oncol Res; 2019 Jan; 25(1):377-389. PubMed ID: 29138985
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway.
Song B; Lin HX; Dong LL; Ma JJ; Jiang ZG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1290-1296. PubMed ID: 29565486
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
[TBL] [Abstract][Full Text] [Related]
16. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A
Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
19. [CRL4B complex promotes the development of pancreatic cancer by inhibiting secreted frizzled related protein 1].
Chen Y; Leng S; Wang Y
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):646-656. PubMed ID: 34289556
[No Abstract] [Full Text] [Related]
20. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]